Search research articles
Contact Us
Filters
Showing results (261-270 of 324) with videos related to
Page
of 33
Sort By:
Frontiers in Immunology
|
June 17, 2021
Sequence-Signature Optimization Enables Improved Identification of Human HV6-1-Derived Class Antibodies That Neutralize Diverse Influenza A Viruses
Gwo-Yu Chuang, Chen-Hsiang Shen, Crystal Sao-Fong Cheung, et al.
NPJ Vaccines
|
October 13, 2017
Protection of calves by a prefusion-stabilized bovine RSV F vaccine
Baoshan Zhang, Lei Chen, Chiara Silacci, et al.
Structure (London, England : 1993)
|
April 30, 2022
Structure of an influenza group 2-neutralizing antibody targeting the hemagglutinin stem supersite
Crystal Sao-Fong Cheung, Jason Gorman, Sarah F Andrews, et al.
Structure (London, England : 1993)
|
April 12, 2022
Structural basis for llama nanobody recognition and neutralization of HIV-1 at the CD4-binding site
Tongqing Zhou, Lei Chen, Jason Gorman, et al.
Journal of Virology
|
March 10, 2017
Structure-Based Design of a Soluble Prefusion-Closed HIV-1 Env Trimer with Reduced CD4 Affinity and Improved Immunogenicity
Gwo-Yu Chuang, Hui Geng, Marie Pancera, et al.
Plos One
|
July 28, 2016
Structure-Based Design of Head-Only Fusion Glycoprotein Immunogens for Respiratory Syncytial Virus
Jeffrey C Boyington, M Gordon Joyce, Mallika Sastry, et al.
Nature
|
November 16, 2012
Broad and potent neutralization of HIV-1 by a gp41-specific human antibody
Jinghe Huang, Gilad Ofek, Leo Laub, et al.
Cell Reports
|
April 9, 2020
Structure of Super-Potent Antibody CAP256-VRC26.25 in Complex with HIV-1 Envelope Reveals a Combined Mode of Trimer-Apex Recognition
Jason Gorman, Gwo-Yu Chuang, Yen-Ting Lai, et al.
Nature Communications
|
January 4, 2019
Lattice engineering enables definition of molecular features allowing for potent small-molecule inhibition of HIV-1 entry
Yen-Ting Lai, Tao Wang, Sijy O'Dell, et al.
Frontiers in Medicine
|
March 25, 2026
Ishak stage 6 fibrosis is more likely to regress than stage 5 in CHB patients undergoing entecavir therapy
Mengjie Li, Xiaogang Hao, Yuanyuan Li, et al.
Page
of 33
Search research articles
Search
Showing results (261-270 of 324) with videos related to
Sort By:
Page
of 33
Frontiers in Immunology
|
June 17, 2021
Sequence-Signature Optimization Enables Improved Identification of Human HV6-1-Derived Class Antibodies That Neutralize Diverse Influenza A Viruses
Gwo-Yu Chuang, Chen-Hsiang Shen, Crystal Sao-Fong Cheung, et al.
NPJ Vaccines
|
October 13, 2017
Protection of calves by a prefusion-stabilized bovine RSV F vaccine
Baoshan Zhang, Lei Chen, Chiara Silacci, et al.
Structure (London, England : 1993)
|
April 30, 2022
Structure of an influenza group 2-neutralizing antibody targeting the hemagglutinin stem supersite
Crystal Sao-Fong Cheung, Jason Gorman, Sarah F Andrews, et al.
Structure (London, England : 1993)
|
April 12, 2022
Structural basis for llama nanobody recognition and neutralization of HIV-1 at the CD4-binding site
Tongqing Zhou, Lei Chen, Jason Gorman, et al.
Journal of Virology
|
March 10, 2017
Structure-Based Design of a Soluble Prefusion-Closed HIV-1 Env Trimer with Reduced CD4 Affinity and Improved Immunogenicity
Gwo-Yu Chuang, Hui Geng, Marie Pancera, et al.
Plos One
|
July 28, 2016
Structure-Based Design of Head-Only Fusion Glycoprotein Immunogens for Respiratory Syncytial Virus
Jeffrey C Boyington, M Gordon Joyce, Mallika Sastry, et al.
Nature
|
November 16, 2012
Broad and potent neutralization of HIV-1 by a gp41-specific human antibody
Jinghe Huang, Gilad Ofek, Leo Laub, et al.
Cell Reports
|
April 9, 2020
Structure of Super-Potent Antibody CAP256-VRC26.25 in Complex with HIV-1 Envelope Reveals a Combined Mode of Trimer-Apex Recognition
Jason Gorman, Gwo-Yu Chuang, Yen-Ting Lai, et al.
Nature Communications
|
January 4, 2019
Lattice engineering enables definition of molecular features allowing for potent small-molecule inhibition of HIV-1 entry
Yen-Ting Lai, Tao Wang, Sijy O'Dell, et al.
Frontiers in Medicine
|
March 25, 2026
Ishak stage 6 fibrosis is more likely to regress than stage 5 in CHB patients undergoing entecavir therapy
Mengjie Li, Xiaogang Hao, Yuanyuan Li, et al.
Page
of 33